Fundz

Glycoera Ag Raises Chf 45 Million (Us$ 49 Million) Series A Financing To Develop Novel Biologics Based On Innovative Glycoengineering Platform

PRIVATENov 05, 2021

Round Type

Series A

WädenswilBiotechnology

Description

GlycoEra AG announced today the close of a CHF 45 million ($49 million) Series A financing round, co-led by renowned US and European life science investors, 5AM Ventures, Roche Venture Fund and Sofinnova Partners. LimmaTech Biologics AG, from which GlycoEra was spun-out, also participated in this round. The proceeds will be used to support the growth of the company and to demonstrate the breadth and value of its CustomGlycan Platform technology in developing assets that can unlock unique biological activities for therapeutic targets in several disease indications.

Quick answer

GlycoEra AG raised an undisclosed amount in a Series A round, dated November 5, 2021. GlycoEra AG is based in Wädenswil, Zurich, Switzerland.

How much did GlycoEra AG raise?
GlycoEra AG raised an undisclosed amount in a Series A round on November 5, 2021.
What does GlycoEra AG do?
GlycoEra is positioned as the leading precision protein degradation company.
Where is GlycoEra AG based and how big is it?
GlycoEra AG is based in Wädenswil, Zurich, Switzerland. Fundz records about 36 employees.
Who are the decision-makers at GlycoEra AG?
Fundz holds 1 contact at GlycoEra AG. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as GlycoEra AG that raised within 45 days of this round, from Fundz verified event records.

  • AGC Biologics raised an undisclosed amount (Grant) on December 20, 2021.
  • Lexaria Bioscience raised $1.2M on December 20, 2021.
  • 20n Bio raised $3.3M (Seed) on December 17, 2021.
  • Cardio Diagnostics Inc. raised $1.1M (Seed) on December 17, 2021.
  • Plastomics raised $7.1M on December 17, 2021.
  • AMBERSTONE BIOSCIENCES, INC. raised $6M on December 17, 2021.

Who to call at GlycoEra AG, and when

A new round usually means GlycoEra AG is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GlycoEra AG raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GlycoEra AG, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GlycoEra AG. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GlycoEra AG

Location

Wädenswil, Zurich, Switzerland

About

GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body. Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GlycoEra AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for GlycoEra AG's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

GlycoEra AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.